Pramila Jayapal addresses Google antitrust case, immigration ruling, and stock trading bill

U.S. Rep. Pramila Jayapal representing Washington's 7th Congressional District
U.S. Rep. Pramila Jayapal representing Washingtons 7th Congressional District
0Comments

Rep. Pramila Jayapal, a U.S. Congresswoman representing Washington’s 7th district since 2017, shared several statements on her official social media account on September 3, 2025, addressing antitrust issues involving Google, a federal court decision affecting Venezuelan deportations, and bipartisan legislation to ban congressional stock trading.

On September 3, Jayapal criticized the outcome of an antitrust case against Google in a post at 14:47 UTC: “Yesterday’s decision in the antitrust case against Google is just a slap on the wrist that will allow the company to stay a monopoly, rigging the game for themselves & hurting consumers.

Full Monopoly Busters Caucus statement with @RepDeluzio, @RepPatRyanNY, and @RepAngieCraig: https://t.co/NN0HziH45s“.

Later that day at 16:30 UTC, she commented on immigration policy and recent legal developments concerning Venezuelan nationals: “BREAKING: A federal court has BLOCKED Trump from using the 18th-century Alien Enemies Act to deport Venezuelans.

This is a win for due process and the rule of law. We will keep fighting these illegal kidnappings in court and in Congress. https://t.co/5hrKlAAfk6“.

At 17:10 UTC, Jayapal promoted legislative efforts targeting congressional ethics reform: “WATCH LIVE: I’m helping to lead a bipartisan coalition to introduce legislation to FINALLY ban Members of Congress from trading stocks https://t.co/lFCc9BPf9z”.

Pramila Jayapal has served as the U.S. Representative for Washington’s 7th District since succeeding Jim McDermott in 2017. Prior to her tenure in Congress, she was a member of the Washington State Senate from 2014 to 2016. Born in Chennai (formerly Madras State) in India in 1965, Jayapal is currently based in Seattle. She holds degrees from Georgetown University (BA) and Northwestern University.



Related

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA inspects Lions World Vision Institute in Seattle for human cellular and gene therapies

FDA records show an April 30 inspection at Lions World Vision Institute in Seattle focused on human cellular, tissue and gene therapy-related activities.

Dr. Mehmet Oz CMS Administrator

Seattle Medicaid spending for Outpatient PPS services rises to $372,042 in 2024

Medicaid payments for Outpatient PPS services in Seattle climbed 9.2% in 2024, highlighting adjustments in service use and payment trends.

Jim Traficant, Chief of Staff of FDA

FDA conducts April 24 inspection at Boeing Commercial Airplane Company in Seattle

The Food and Drug Administration visited Boeing Commercial Airplane Company in Seattle on April 24 to provide technical assistance regarding food and cosmetics, according to information from the FDA’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Seattle City Wire.